Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The MMP1 and MMP13 promoter polymorphisms were not associated with lung cancer risk, while the C/G polymorphism in MMP8 was associated with a statistically significant decreased risk of developing lung cancer (ORadj = 0.65; 95%CI = 0.45-0.93).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP388481.RAaN9eZsWp9KHsxP2EiQq0Yuu2hMHNLmqf22vZN_0PlME130_assertion description "[The MMP1 and MMP13 promoter polymorphisms were not associated with lung cancer risk, while the C/G polymorphism in MMP8 was associated with a statistically significant decreased risk of developing lung cancer (ORadj = 0.65; 95%CI = 0.45-0.93).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP388481.RAaN9eZsWp9KHsxP2EiQq0Yuu2hMHNLmqf22vZN_0PlME130_provenance.
• NP188506.RAqmEKcoq5y1AHbQ3nBChpi32qLAiJejMvtwrfvGEWhVQ130_assertion description "[The MMP1 and MMP13 promoter polymorphisms were not associated with lung cancer risk, while the C/G polymorphism in MMP8 was associated with a statistically significant decreased risk of developing lung cancer (ORadj = 0.65; 95%CI = 0.45-0.93).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP188506.RAqmEKcoq5y1AHbQ3nBChpi32qLAiJejMvtwrfvGEWhVQ130_provenance.
• NP438475.RAePRS6RtMVG3bZIyEHa2bq6t8V2KeF0NsN5oeF13Knwk130_assertion description "[The MMP1 and MMP13 promoter polymorphisms were not associated with lung cancer risk, while the C/G polymorphism in MMP8 was associated with a statistically significant decreased risk of developing lung cancer (ORadj = 0.65; 95%CI = 0.45-0.93).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP438475.RAePRS6RtMVG3bZIyEHa2bq6t8V2KeF0NsN5oeF13Knwk130_provenance.
• NP560863.RAQYGeSASA3QnK9SAZ8itpa72r6cEWigVILzvqD8oXyJQ130_assertion description "[The MMP1 and MMP13 promoter polymorphisms were not associated with lung cancer risk, while the C/G polymorphism in MMP8 was associated with a statistically significant decreased risk of developing lung cancer (ORadj = 0.65; 95%CI = 0.45-0.93).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP560863.RAQYGeSASA3QnK9SAZ8itpa72r6cEWigVILzvqD8oXyJQ130_provenance.
• assertion description "[The MMP1 and MMP13 promoter polymorphisms were not associated with lung cancer risk, while the C/G polymorphism in MMP8 was associated with a statistically significant decreased risk of developing lung cancer (ORadj = 0.65; 95%CI = 0.45-0.93).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The MMP1 and MMP13 promoter polymorphisms were not associated with lung cancer risk, while the C/G polymorphism in MMP8 was associated with a statistically significant decreased risk of developing lung cancer (ORadj = 0.65; 95%CI = 0.45-0.93).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The MMP1 and MMP13 promoter polymorphisms were not associated with lung cancer risk, while the C/G polymorphism in MMP8 was associated with a statistically significant decreased risk of developing lung cancer (ORadj = 0.65; 95%CI = 0.45-0.93).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The MMP1 and MMP13 promoter polymorphisms were not associated with lung cancer risk, while the C/G polymorphism in MMP8 was associated with a statistically significant decreased risk of developing lung cancer (ORadj = 0.65; 95%CI = 0.45-0.93).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The MMP1 and MMP13 promoter polymorphisms were not associated with lung cancer risk, while the C/G polymorphism in MMP8 was associated with a statistically significant decreased risk of developing lung cancer (ORadj = 0.65; 95%CI = 0.45-0.93).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The MMP1 and MMP13 promoter polymorphisms were not associated with lung cancer risk, while the C/G polymorphism in MMP8 was associated with a statistically significant decreased risk of developing lung cancer (ORadj = 0.65; 95%CI = 0.45-0.93).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP92814.RAkYUBauMWt-bsWl8RRT3_fUeC17k7Khh38oEwAcNmG2Y130_assertion description "[The MMP1 and MMP13 promoter polymorphisms were not associated with lung cancer risk, while the C/G polymorphism in MMP8 was associated with a statistically significant decreased risk of developing lung cancer (ORadj = 0.65; 95%CI = 0.45-0.93).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92814.RAkYUBauMWt-bsWl8RRT3_fUeC17k7Khh38oEwAcNmG2Y130_provenance.
• NP560998.RApzOQb8ITvXg0AlmRsqbynozOvApr-7dGu1om07tbMp4130_assertion description "[The MMP1 and MMP13 promoter polymorphisms were not associated with lung cancer risk, while the C/G polymorphism in MMP8 was associated with a statistically significant decreased risk of developing lung cancer (ORadj = 0.65; 95%CI = 0.45-0.93).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP560998.RApzOQb8ITvXg0AlmRsqbynozOvApr-7dGu1om07tbMp4130_provenance.
• NP68560.RA6ztoBzABu7xSPFyRxwS3lIjoztdix5k5ifPs4zHHpcQ130_assertion description "[The MMP1 and MMP13 promoter polymorphisms were not associated with lung cancer risk, while the C/G polymorphism in MMP8 was associated with a statistically significant decreased risk of developing lung cancer (ORadj = 0.65; 95%CI = 0.45-0.93).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP68560.RA6ztoBzABu7xSPFyRxwS3lIjoztdix5k5ifPs4zHHpcQ130_provenance.
• NP565913.RAIIR1_51K4NNpx9C8p19M-Veu4VljtuZ1VhpFgRbdVPY130_assertion description "[The MMP1 and MMP13 promoter polymorphisms were not associated with lung cancer risk, while the C/G polymorphism in MMP8 was associated with a statistically significant decreased risk of developing lung cancer (ORadj = 0.65; 95%CI = 0.45-0.93).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565913.RAIIR1_51K4NNpx9C8p19M-Veu4VljtuZ1VhpFgRbdVPY130_provenance.
• NP565959.RAO3koFdvPnwNpjRu4g1oXHAgQM8dN9Pgz62kM00LzVU4130_assertion description "[The MMP1 and MMP13 promoter polymorphisms were not associated with lung cancer risk, while the C/G polymorphism in MMP8 was associated with a statistically significant decreased risk of developing lung cancer (ORadj = 0.65; 95%CI = 0.45-0.93).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565959.RAO3koFdvPnwNpjRu4g1oXHAgQM8dN9Pgz62kM00LzVU4130_provenance.